Cytokinetics Incorporated

(CYTK) Trade

By |

Profile

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Contact Information

Website: www.cytokinetics.com
Email: investor@cytokinetics.com
Main Phone: +1 650 624-3000
Address: 280 East Grand Avenue
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Robert I. Blum
Employees: 130
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Contact Information

Website: www.cytokinetics.com
Email: investor@cytokinetics.com
Main Phone: +1 650 624-3000
Address: 280 East Grand Avenue
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Robert I. Blum
Employees: 130
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 12.14 $ -0.47 (-3.73%)
Last Price 12.14 Change $ -0.47 Change % -3.73 Tick N/A
Bid 11.10 Bid Size 100.00 Ask 14.39 Ask Size 500.00
Open 12.74 High 12.80 Low 12.04 Prev Close 12.61
Last Trade Volume 775,805 52 Wk Hi 14.94 52 Wk Low 5.75
Market Cap 718.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 59,161,037.00 EPS (TTM) -2.08 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 222
Number of Buys 0 49
Number of Sells 7 173
Net Activity -15000 220011
Last 10 Buys Shares
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
L. Patrick Gage 1,000
Last 10 Sell Shares
Fady Ibraham Malik 1,000
Robert I. Blum 1,000
Robert I. Blum 1,000
Robert I. Blum 1,000
Robert I. Blum 1,000
Robert I. Blum 1,000
Robert I. Blum 1,000
Caryn McDowell 1,000
Caryn McDowell 1,000
Caryn McDowell 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 15 15 14.43 15
Standard Deviation 4.15 4.15 4.08 4.15
Date of Most Recent Estimate 05/01/18 05/01/18 05/01/18 05/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 4
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.58 1.58 1.58 1.5